{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:23:53Z","timestamp":1786123433380,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Cardiac surgery with cardiopulmonary bypass induces a profound inflammatory response that, when severe, can lead to multiorgan system dysfunction. Preliminary data suggest that administration of hydroxyethyl starch (HES) solutions may mitigate an inflammatory response and improve pulmonary function. Our goal was to examine the effect of 6% HES 130\/0.4 versus 5% human albumin given for intravascular plasma volume replacement on the perioperative inflammatory response and pulmonary function in patients undergoing cardiac surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      This was a subinvestigation of a blinded, parallel-group, randomized clinical trial of patients undergoing elective aortic valve replacement surgery at the Cleveland Clinic main campus, titled \u201cEffect of 6% Hydroxyethyl Starch 130\/0.4 on Kidney and Haemostatic Function in Cardiac Surgical Patients.\u201d Of 141 patients who were randomized to receive either 6% HES 130\/0.4 or 5% human albumin for intraoperative plasma volume replacement, 135 patients were included in the data analysis (HES n = 66, albumin n = 69). We assessed the cardiopulmonary bypass\u2013induced inflammatory response end points by comparing the 2 groups\u2019 serum concentrations of tumor necrosis factor-alpha (TNF-\u03b1), interleukin-6 (IL-6), and macrophage migration inhibitory factor (MIF), measured at baseline and at 1 and 24 hours after surgery. We also compared the 2 groups\u2019 postoperative pulmonary function end points, including the ratio of partial pressure of arterial oxygen to fraction of inspired oxygen (Pa\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      :F\n                      <jats:sc>io<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      ratio), dynamic lung compliance, oxygenation index (OI), and ventilation index (VI) at baseline, within 1 hour of arrival to the intensive care unit, and before tracheal extubation. The differences in the postoperative levels of inflammatory response and pulmonary function between the HES and albumin groups were assessed individually in linear mixed models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Serum concentrations of the inflammatory markers (TNF-\u03b1, IL-6, MIF) were not significantly different (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2265 .05) between patients who received 6% HES 130\/0.4 or 5% albumin, and there was no significant heterogeneity of the estimated treatment effect over time (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2265 .15). The results of pulmonary function parameters (Pa\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      :F\n                      <jats:sc>io<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      ratio, dynamic compliance, OI, VI) were not significantly different (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2265 .05) between groups, and there was no significant heterogeneity of the estimated treatment effect over time (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2265 .15).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Our investigation found no significant difference in the concentrations of inflammatory markers and measures of pulmonary function between cardiac surgical patients who received 6% HES 130\/0.4 versus 5% albumin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000005664","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T10:04:32Z","timestamp":1629281072000},"page":"906-914","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Effect of 6% Hydroxyethyl Starch 130\/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial"],"prefix":"10.1213","volume":"133","author":[{"given":"Mee Jee","family":"Lee","sequence":"first","affiliation":[{"name":"Anesthesiology Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Tannenbaum","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangmei","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Outcomes Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Outcomes Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Outcomes Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin O\u011fuz","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Outcomes Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker","family":"Ince","sequence":"additional","affiliation":[{"name":"Department of Outcomes Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Soltesz","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andra E.","family":"Duncan","sequence":"additional","affiliation":[{"name":"Department of Outcomes Research"},{"name":"Department of Cardiothoracic Anesthesia, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"S715","DOI":"10.1016\/S0003-4975(02)04701-X","article-title":"Inflammatory response to cardiopulmonary bypass.","volume":"75","author":"Levy","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/PL00012432","article-title":"Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes.","volume":"51","author":"Holmes","year":"2002","journal-title":"Inflamm Res"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jss.2009.05.050","article-title":"Hydroxyethyl starch 130\/0.4 inhibits production of plasma proinflammatory cytokines and attenuates nuclear factor-kappaB activation and toll-like receptors expression in monocytes during sepsis.","volume":"160","author":"Xie","year":"2010","journal-title":"J Surg Res"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"726243","DOI":"10.1155\/2015\/726243","article-title":"In vivo evaluation of the ameliorating effects of small-volume resuscitation with four different fluids on endotoxemia-induced kidney injury.","volume":"2015","author":"Wang","year":"2015","journal-title":"Mediators Inflamm"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00000542-200701000-00016","article-title":"Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study.","volume":"106","author":"Volta","year":"2007","journal-title":"Anesthesiology"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cyto.2014.10.002","article-title":"Immune and inflammatory role of hydroxyethyl starch 130\/0.4 and fluid gelatin in patients undergoing coronary surgery.","volume":"74","author":"\u00d6zt\u00fcrk","year":"2015","journal-title":"Cytokine"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1213\/01.ANE.0000099720.25581.86","article-title":"The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms.","volume":"98","author":"Tian","year":"2004","journal-title":"Anesth Analg"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jss.2006.02.028","article-title":"Effects of hydroxyethyl starch 130\/0.4 on pulmonary capillary leakage and cytokines production and NF-kappaB activation in CLP-induced sepsis in rats.","volume":"135","author":"Feng","year":"2006","journal-title":"J Surg Res"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.trsl.2010.12.009","article-title":"Hydroxyethyl starch reduces high stretch ventilation-augmented lung injury via vascular endothelial growth factor.","volume":"157","author":"Li","year":"2011","journal-title":"Transl Res"},{"key":"R10-20250502","first-page":"1113","article-title":"Modulation of inflammation during acute normovolemic anemia with different fluid replacement.","volume":"79","author":"Kahvegian","year":"2013","journal-title":"Minerva Anestesiol"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/01.CIR.88.2.726","article-title":"Peripheral bypass-induced pulmonary and coronary vascular injury. Association with increased levels of tumor necrosis factor.","volume":"88","author":"Dauber","year":"1993","journal-title":"Circulation"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF00941649","article-title":"Relationship between respiratory distress and cytokine response after cardiopulmonary bypass.","volume":"27","author":"Ito","year":"1997","journal-title":"Surg Today"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/clin.1997.4413","article-title":"Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response\/multiple organ dysfunction syndromes.","volume":"85","author":"Khabar","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/anae.14994","article-title":"Effect of 6% hydroxyethyl starch 130\/0.4 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial.","volume":"75","author":"Duncan","year":"2020","journal-title":"Anaesthesia"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biopha.2015.01.021","article-title":"Induction of vascular leak syndrome by tumor necrosis factor-alpha alone.","volume":"70","author":"Park","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0022-5223(95)70028-5","article-title":"Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor.","volume":"110","author":"te Velthuis","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0008-6363(95)00101-8","article-title":"Effects of inflammatory cytokines on vascular tone.","volume":"30","author":"Ohkawa","year":"1995","journal-title":"Cardiovasc Res"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-5223(94)70484-8","article-title":"A potential mechanism of vasodilation after warm heart surgery. The temperature-dependent release of cytokines.","volume":"107","author":"Menasch\u00e9","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/0003-4975(96)00055-0","article-title":"Systemic inflammatory response syndrome after cardiac operations.","volume":"61","author":"Cremer","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1213\/ANE.0b013e3181f333aa","article-title":"The relationship between inflammatory activation and clinical outcome after infant cardiopulmonary bypass.","volume":"111","author":"Allan","year":"2010","journal-title":"Anesth Analg"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1213\/01.ANE.0000078574.76915.11","article-title":"Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery.","volume":"97","author":"Tomasdottir","year":"2003","journal-title":"Anesth Analg"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jtcvs.2004.02.022","article-title":"Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor beta as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass.","volume":"128","author":"Gr\u00fcnenfelder","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0003-4975(96)00230-5","article-title":"Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting.","volume":"62","author":"Deng","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0022-5223(94)70286-1","article-title":"Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization.","volume":"108","author":"Hennein","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/01.shk.0000142817.84070.df","article-title":"Circulating levels of macrophage migration inhibitory factor are associated with mild pulmonary dysfunction after cardiopulmonary bypass.","volume":"22","author":"de Mendon\u00e7a-Filho","year":"2004","journal-title":"Shock"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2119\/molmed.2012.00071","article-title":"High postoperative blood levels of macrophage migration inhibitory factor are associated with less organ dysfunction in patients after cardiac surgery.","volume":"18","author":"Stoppe","year":"2012","journal-title":"Mol Med"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"eaan4886","DOI":"10.1126\/scitranslmed.aan4886","article-title":"The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery.","volume":"10","author":"Stoppe","year":"2018","journal-title":"Sci Transl Med"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2174\/1389557515666150203143736","article-title":"The role of macrophage migration inhibitory factor in critical illness.","volume":"14","author":"Rex","year":"2014","journal-title":"Mini Rev Med Chem"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2253-14-83","article-title":"Evaluation of the PaO2\/FiO2 ratio after cardiac surgery as a predictor of outcome during hospital stay.","volume":"14","author":"Esteve","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1017\/S0265021505001870","article-title":"Predictors of mortality in ARDS patients referred to a tertiary care centre: a pilot study.","volume":"23","author":"Luecke","year":"2006","journal-title":"Eur J Anaesthesiol"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1097\/CCM.0b013e318170a375","article-title":"Predictors of hospital mortality in a population-based cohort of patients with acute lung injury.","volume":"36","author":"Cooke","year":"2008","journal-title":"Crit Care Med"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/cc7150","article-title":"Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients.","volume":"12","author":"de Jonge","year":"2008","journal-title":"Crit Care"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM198102263040901","article-title":"Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.","volume":"304","author":"Chenoweth","year":"1981","journal-title":"N Engl J Med"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-5223(19)39061-0","article-title":"Complement and the damaging effects of cardiopulmonary bypass.","volume":"86","author":"Kirklin","year":"1983","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1097\/PCC.0000000000000759","article-title":"Cardiopulmonary bypass-induced inflammatory response: pathophysiology and treatment.","volume":"17","author":"Bronicki","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"R37-20250502","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/026765910101600505","article-title":"Systemic inflammation and cardiac surgery: an update.","volume":"16","author":"Asimakopoulos","year":"2001","journal-title":"Perfusion"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00000658-198708000-00015","article-title":"A comparison between 25% albumin and 6% hydroxyethyl starch solutions on lung water accumulation during and immediately after cardiopulmonary bypass.","volume":"206","author":"Lumb","year":"1987","journal-title":"Ann Surg"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:34:40Z","timestamp":1786113280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000005664","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,18]]}}}